Related Experiment Video
Updated: May 30, 2026
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
SDF-1/CXCR4 axis in myelodysplastic syndromes: correlation with angiogenesis and apoptosis
Yizhuo Zhang1, Haifeng Zhao, Dandan Zhao
1Department of Hematology, TianJin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, PR China. zhangzhurensci@yahoo.cn
Abstract:
To study the role of SDF-1/CXCR4 axis in MDS, the expression of SDF-1 and CXCR4, VEGF, MVD and apoptosis were measured in MDS. The results showed that the expression of SDF-1 of the low-grade MDS is higher than that of the high-grade MDS and the control. The high-grade MDS had a significantly higher CXCR4 expression on CD34+ cell than low-grade MDS and the control. It was suggested that the SDF-1/CXCR4 axis play an important role in MDS. Apoptosis was significantly increased in low-grade MDS, compared with high-grade MDS. The expression of VEGF and MVD were higher in the high-grade MDS than in the low-grade MDS. There are positive correlations between SDF-1 and apoptosis in the low-grade MDS. For the high-grade MDS, there were positive correlations between CXCR4 and VEGF, and between SDF-1 concentration and MVD. The apoptosis is one of the hallmarks for low-grade MDS and the angiogenesis for high-grade MDS. A refined understanding of the roles that SDF-1/CXCR4 axis and its correlation with angiogenesis and apoptosis play in MDS will fuel the development of therapies that can be targeted to the SDF-1/CXCR4 axis.
Insights
The SDF-1/CXCR4 axis is crucial in myelodysplastic syndromes (MDS). Its role differs between low-grade MDS (apoptosis) and high-grade MDS (angiogenesis), informing targeted therapy development.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- The role of the stromal cell-derived factor-1 (SDF-1)/chemokine receptor type 4 (CXCR4) axis in MDS pathogenesis is not fully understood.
- Understanding this axis is critical for developing targeted therapies.
Purpose of the Study:
- To investigate the expression of SDF-1 and CXCR4 in MDS.
- To explore the correlation of the SDF-1/CXCR4 axis with angiogenesis (VEGF, MVD) and apoptosis in MDS.
- To elucidate the distinct roles of the SDF-1/CXCR4 axis in low-grade versus high-grade MDS.
Main Methods:
- Quantitative analysis of SDF-1 and CXCR4 expression in MDS patient samples.
- Measurement of vascular endothelial growth factor (VEGF) and microvessel density (MVD) as markers of angiogenesis.
- Assessment of apoptosis levels in different grades of MDS.
- Correlation analysis between SDF-1/CXCR4 axis components and clinical/biological parameters.
Main Results:
- SDF-1 expression was higher in low-grade MDS than high-grade MDS and controls.
- CXCR4 expression on CD34+ cells was significantly higher in high-grade MDS compared to low-grade MDS and controls.
- Apoptosis was elevated in low-grade MDS, while VEGF and MVD were higher in high-grade MDS.
- Positive correlations were observed between SDF-1 and apoptosis in low-grade MDS, and between CXCR4, SDF-1, and angiogenesis markers in high-grade MDS.
Conclusions:
- The SDF-1/CXCR4 axis plays a significant role in MDS pathogenesis.
- Apoptosis is a hallmark of low-grade MDS, whereas angiogenesis is characteristic of high-grade MDS.
- Targeting the SDF-1/CXCR4 axis, considering its differential roles and correlations with apoptosis and angiogenesis, holds promise for novel MDS therapies.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:10Mechanism of Angiogenesis